ID 522 - Olej rybi

PL: Olej rybi
EN: Fish Oil
Pdf: eicosapentaenoic acid

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent which is the subject of the health claims is mixed long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA), namely docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA) and, for ID 703, with docosapentaenoic acid (DPA).
The n-3 LCPUFA EPA, DHA and DPA are recognised nutrients and are measurable in foods by established methods. They are well absorbed when consumed in the form of triglycerides. This evaluation applies to EPA, DHA and, for ID 703, DPA from all sources with suitable bioavailability in the specified amounts.
The Panel considers that the food constituent, EPA, DHA and DPA, which is the subject of the health claims, is sufficiently characterised.

2.8. Zwiększenie biodostępności kwasów EPA i DHA (ID 522, 523)

The claimed effects are “intake of emulsified fish oil improves the digestion and absorption of omega- 3 fatty acids” and “intake of emulsified cod liver oil improves the digestion and absorption of omega- 3 fatty acids”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effects relate to an improved absorption of EPA and DHA from emulsified fish oils as compared to other (non emulsified) sources of EPA and DHA.
Regulation (EC) No 1924/2006 defines health claims made on foods as “any claim that states, suggests or implies that a relationship exists between a food category, a food or one of its constituents and health” (Article 2.5), whereas that “the nutrient or other substance for which the claim is made is in a form that is available to be used by the body” (Article 5.1(c)) is a general condition for all claims.
The Panel notes that the claimed effects relate to the improved absorption of the food constituents (EPA and DHA) rather than to the relationship between a food constituent and health as required by
Regulation (EC) No 1924/2006.

Warunki i możliwe ograniczenia stosowania oświadczenia

5-10ml per day